Encore Revelation Hip Stem

NCT01514318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2012-11-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to obtain long-term (10+ yrs) clinical and patient outcomes data on patients who received the Revelation Hip Stem prior to 2002.

Conditions

  • Osteoarthritis, Hip
  • Complications; Arthroplasty

Interventions

DEVICE

Revelation Hip Stem (Revelation)

Subjects who received the Revelation Hip Stem prior to 2002 and still maintain the original device.

Sponsors & Collaborators

  • DJO Incorporated

    collaborator INDUSTRY
  • Encore Medical, L.P.

    lead INDUSTRY

Principal Investigators

  • Frosty Moore, M.D. · Westlake Orthopaedics Spine & Sports

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01514318 on ClinicalTrials.gov